US FDA announcement on LNG EC efficacy and weight
On May 24, 2016, the United States Food and Drug Administration (FDA) announced completion of a review of the existing data related to the efficacy of EC and body weight, concluding that the data do not warrant a change to product labels: “The FDA has completed a review of available scientific data concerning the effectiveness of levonorgestrel (LNG)…